Copyright
©The Author(s) 2024.
World J Diabetes. Jun 15, 2024; 15(6): 1272-1279
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1272
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1272
Healthy subjects (n = 101) | T2DM (n = 97) | T2DM + HP (n = 70) | P1 value | Ptrend value | |
GLSepi, % | -18.66 ± 1.58 | -17.33 ± 1.931 | -16.74 ± 1.931,2 | < 0.001 | < 0.001 |
GLSmid, % | -21.58 ± 1.843 | -19.87 ± 2.211,3 | -19.28 ± 2.161,3 | < 0.001 | < 0.001 |
GLSendo, % | -25.03 ± 2.243,4 | -22.97 ± 2.561,3,4 | -22.48 ± 2.501,3,4 | < 0.001 | < 0.001 |
PSD, msec | 28.79 ± 7.25 | 34.92 ± 11.191 | 39.23 ± 11.471,2 | < 0.001 | < 0.001 |
P2 value | < 0.001 | < 0.001 | < 0.001 |
- Citation: Chen ZG, Li GA, Huang J, Fan L. Subclinical impairment of left ventricular myocardium function in type 2 diabetes mellitus patients with or without hypertension. World J Diabetes 2024; 15(6): 1272-1279
- URL: https://www.wjgnet.com/1948-9358/full/v15/i6/1272.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i6.1272